Esophageal Cancer Clinical Trial

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Summary

This trial tests whether planning for your advance care needs (PLAN) intervention works to enhance Latino patients' understanding of and engagement in advanced care planning. PLAN intervention may be an effective method to help people with cancer plan for and talk about advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors.

View Full Description

Full Description

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients participate in PLAN intervention, consisting of 3 coaching sessions over 45-60 minutes each with a health coach.

ARM II: Patients receive usual care.

After completion of study treatment, patients are followed up at 1 week and then at 3 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Identifying ethnically as Latino.
Locally advanced or metastatic cancer (pancreaticobiliary, esophagogastric, hepatocellular carcinoma, lung, or gynecological cancer) AND have experienced disease progression on at least first-line chemotherapy.
Ability to provide informed consent.

Exclusion Criteria:

Not fluent in English or Spanish.
Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of >= 6 to be delivered by trained study research staff during screening).
Too ill or weak to complete the interviews (as judged by interviewer).
Currently receiving palliative care/hospice at the time of enrollment (to allow prediction of [advanced care planning] ACP).
Children and young adults under age 21.
Patients deemed inappropriate for the study by their treating oncologist.

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

50

Study ID:

NCT04889144

Recruitment Status:

Recruiting

Sponsor:

Fred Hutchinson Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Weill Cornell Medicine
New York New York, 10021, United States
UT Southwestern/Simmons Cancer Center-Dallas
Dallas Texas, 75390, United States More Info
Elizabeth Paulk, MD
Contact
214-648-2992
[email protected]
Elizabeth Paulk, MD
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Seattle Washington, 98109, United States More Info
Claudia De Los Santos, BS
Contact
206-667-1565
[email protected]
Megan J Shen, PhD
Contact
206-667-4172
[email protected]
Megan J Shen, PhD
Principal Investigator
Confluence Health
Wenatchee Washington, 98801, United States More Info
Lindsay Overton, MD
Contact
509-663-8711
[email protected]
Lindsay Overton, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

50

Study ID:

NCT04889144

Recruitment Status:

Recruiting

Sponsor:


Fred Hutchinson Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.